Hemodynamic Support Devices

This hemodynamic support systems include intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or tandemheart, and ventricular assist devices (VAD).

SynCardia, Total Artificial Heart, 50cc, FDA, investigational study
News | April 02, 2015

April 2, 2015 — SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an...

Impella, FDA, high risk PCI, abiomed

Abiomed's Impella 2.5 now has an FDA indication for high-risk PCI.

Technology | March 25, 2015

March 24, 2015 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for...

News | January 30, 2015

January 30, 2015 — SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a...

Thoratec, HeartMate III, VAD, NewYork Presbyterian, trial, ventricular assist

HeartMate III image courtesy of Thoratec

News | January 27, 2015

January 27, 2015 — NewYork-Presbyterian Hospital/Columbia University Medical Center is one of a select group of...

absorb, bioresorbable stents

Content that included bioresorbable stents were among some of the most popular stories in 2014. An image of Abbott's Absorb bioresorbable scaffold.

Feature | December 30, 2014 | Dave Fornell
DAIC readers chose the following stories as the most popular content in 2014, based on website analytics. The list is...
Hemodynamic support devices, Resuscitation Devices, Zoll Medical Corp.

Image courtesy of Advanced Circulatory Systems

News | December 30, 2014

December 30, 2014 — Zoll Medical Corp. announced that it will acquire Advanced Circulatory Systems Inc.


News | October 09, 2014

October 9, 2014 — CardiacAssist Inc. announced that the first Protek Duo veno-venous extracorporeal life support (VV...

Feature | October 08, 2014

September 16, 2014 – Clinical trial results by Recover Right revealed a survival rate of 73 percent in the total...

St. Vincent Implant Thoratec Corp. HeartMate III VAD
News | October 06, 2014

October 6, 2014 — St. Vincent Heart Center officials announced that the faith-based hospital is the second in the...

heartmate III, tohratec, heart failure, heart failure treatment

HeartMate III

News | September 29, 2014
September 29, 2014 – Thoratec Corporation announced that it has begun to enroll patients in the HeartMate III U.S....
VADs Gain Popularity Artificial Hearts Remain Ideal GlobalData
Feature | September 22, 2014

September 22, 2014 — Robert Littlefield, MSc, GlobalData's senior analyst covering Medical Devices, said:


Technology | September 05, 2014

September 5, 2014 — CardiacAssist announced it has received 510(k) clearance from the U.S. Food and Drug...

News | August 29, 2014

August 29, 2014 — CardiacAssist announced it has received a Class 2 medical device license from Health Canada for...

MYDICAR Celladon Corp. Clinical Trial Heart Failure Treatments LVADs
News | August 13, 2014

August 13, 2014 — Celladon Corp. announced that the first patient has been dosed in a...

SynCardia Total Artificial Heart SynHall Valves FDA approval

SynCardia Systems Inc. received FDA approval to manufacture the SynCardia Total Artificial Heart with SynHall valves. The OK gives the company control over the two critical components for heart manufacturing: The valves and the unique formula for segmented polyurethane solution (SPUS), which is manufactured only by SynCardia.

Technology | August 11, 2014

August 11, 2014 — SynCardia Systems Inc. received approval in July from the U.S. Federal Drug Administration (FDA)...

Overlay Init